<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present the clinical and serological characteristics of four patients with rhupus (Simon's definition) </plain></SENT>
<SENT sid="1" pm="."><plain>The 4 patients with rhupus presented ACR criteria for SLE as well as for RA, ANA positive with titers ranging from 1/80 to 1/5,250, and positive anti-DNA, with the predominance of symmetrical erosive <z:e sem="disease" ids="C0162323" disease_type="Disease or Syndrome" abbrv="">polyarthritis</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We found anti-<z:chebi fb="97" ids="35889">CCP</z:chebi> positivity and high titers in 3 of the 4 patients, and positive <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in 2 (anticardiolipin and LA), without manifestation of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>One patient presented renal affection, and 2 <z:hpo ids='HP_0001482'>subcutaneous nodules</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The 3 patients with RA preceded the manifestations of SLE by an average of 7.7 years </plain></SENT>
<SENT sid="5" pm="."><plain>Two patients were refractory to conventional DMAR in combination, requiring biologic and mycophennolate mofetil </plain></SENT>
</text></document>